We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Necessity spawns invention

26 January 2005 By Chris Hughes

Derivatives are a common way for insurers to cut their equity exposure. But this one will be sold publicly. It’s part of a E4bn fundraising, in which Allianz hopes to exploit investors’ current appetites rather than dumping shares on the market.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)